Gut microbiota-derived imidazole propionate is a novel marker of cardiometabolic risk in patients with coronary artery disease
30 August 2025 (10:15 - 11:00)
Organised by: 

About the speaker

University of Zurich, Zurich (Switzerland)
7 More presentations in this session

Doctor L. Spray (Newcastle-Upon-Tyne, GB)

Doctor T. Kufazvinei (Oxford, GB)
Access the full session
The Event
ESC Congress 2025
30 August 2025
10:15 CET
You may be interested in
Congress Presentation



